Octozi is a revenue-generating seed-stage company building AI agents for clinical development workflows. We’re cutting the cost and time of bringing drugs to market by improving the science and analysis of clinical data. We already have commercial contracts with multiple pharma companies and are scaling the team to meet demand, tackling problems like agent orchestration over messy clinical datasets, human-in-the-loop review at scale, and turning unstructured medical reasoning into regulator-ready output.